vs

LG化学(CHE)与Rapid7, Inc.(RPD)财务数据对比。点击上方公司名可切换其他公司

LG化学的季度营收约是Rapid7, Inc.的1.9倍($420.0M vs $217.4M),LG化学净利率更高(15.8% vs 1.4%,领先14.3%),LG化学同比增速更快(3.1% vs 0.5%),过去两年LG化学的营收复合增速更高(5.9% vs 3.0%)

LG化学是韩国最大的化工企业,总部位于韩国首尔,2021年按销售额统计为全球第九大化工企业。其前身为生产化妆品的乐喜化学工业株式会社,目前已全面转型为仅面向企业客户的B2B经营模式。

Rapid7是全球领先的网络安全企业,提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案,服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户,助力客户高效识别、应对和缓解网络安全风险。

CHE vs RPD — 直观对比

营收规模更大
CHE
CHE
是对方的1.9倍
CHE
$420.0M
$217.4M
RPD
营收增速更快
CHE
CHE
高出2.6%
CHE
3.1%
0.5%
RPD
净利率更高
CHE
CHE
高出14.3%
CHE
15.8%
1.4%
RPD
两年增速更快
CHE
CHE
近两年复合增速
CHE
5.9%
3.0%
RPD

损益表 — Q1 FY2026 vs Q4 FY2025

指标
CHE
CHE
RPD
RPD
营收
$420.0M
$217.4M
净利润
$66.3M
$3.1M
毛利率
68.9%
营业利润率
20.1%
1.0%
净利率
15.8%
1.4%
营收同比
3.1%
0.5%
净利润同比
44.1%
每股收益(稀释后)
$0.05

绿色 = 该指标领先。财年不对齐时期间可能不同

8季度营收与利润趋势

并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配

营收
CHE
CHE
RPD
RPD
Q1 26
$420.0M
Q4 25
$639.3M
$217.4M
Q3 25
$624.9M
$218.0M
Q2 25
$618.8M
$214.2M
Q1 25
$646.9M
$210.3M
Q4 24
$411.0M
$216.3M
Q3 24
$391.4M
$214.7M
Q2 24
$374.6M
$208.0M
净利润
CHE
CHE
RPD
RPD
Q1 26
$66.3M
Q4 25
$76.8M
$3.1M
Q3 25
$64.2M
$9.8M
Q2 25
$52.5M
$8.3M
Q1 25
$71.8M
$2.1M
Q4 24
$90.3M
$2.2M
Q3 24
$75.8M
$15.4M
Q2 24
$70.9M
$6.5M
毛利率
CHE
CHE
RPD
RPD
Q1 26
Q4 25
35.2%
68.9%
Q3 25
31.5%
70.2%
Q2 25
29.8%
70.6%
Q1 25
33.5%
71.7%
Q4 24
1.2%
69.5%
Q3 24
-1.2%
70.6%
Q2 24
-4.1%
70.7%
营业利润率
CHE
CHE
RPD
RPD
Q1 26
20.1%
Q4 25
15.7%
1.0%
Q3 25
12.0%
2.7%
Q2 25
11.0%
1.6%
Q1 25
14.6%
-0.0%
Q4 24
27.7%
3.4%
Q3 24
23.5%
6.0%
Q2 24
23.5%
2.5%
净利率
CHE
CHE
RPD
RPD
Q1 26
15.8%
Q4 25
12.0%
1.4%
Q3 25
10.3%
4.5%
Q2 25
8.5%
3.9%
Q1 25
11.1%
1.0%
Q4 24
22.0%
1.0%
Q3 24
19.4%
7.2%
Q2 24
18.9%
3.1%
每股收益(稀释后)
CHE
CHE
RPD
RPD
Q1 26
Q4 25
$5.45
$0.05
Q3 25
$4.46
$0.15
Q2 25
$3.57
$0.13
Q1 25
$4.86
$0.03
Q4 24
$6.00
$0.08
Q3 24
$5.00
$0.21
Q2 24
$4.65
$0.09

资产负债表与财务实力

最新季度各公司的流动性、杠杆与账面价值一览

指标
CHE
CHE
RPD
RPD
现金及短期投资手头流动性
$16.9M
$474.7M
总债务越低越好
$91.2M
股东权益账面价值
$848.0M
$154.7M
总资产
$1.5B
$1.7B
负债/权益比越低杠杆越低
0.11×

8季度趋势,按日历期对齐

现金及短期投资
CHE
CHE
RPD
RPD
Q1 26
$16.9M
Q4 25
$74.5M
$474.7M
Q3 25
$129.8M
$407.1M
Q2 25
$249.9M
$511.7M
Q1 25
$173.9M
$493.5M
Q4 24
$178.3M
$521.7M
Q3 24
$238.5M
$443.7M
Q2 24
$222.9M
$442.6M
总债务
CHE
CHE
RPD
RPD
Q1 26
$91.2M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
股东权益
CHE
CHE
RPD
RPD
Q1 26
$848.0M
Q4 25
$979.4M
$154.7M
Q3 25
$1.1B
$127.2M
Q2 25
$1.2B
$90.4M
Q1 25
$1.2B
$52.7M
Q4 24
$1.1B
$17.7M
Q3 24
$1.2B
$-5.1M
Q2 24
$1.2B
$-52.6M
总资产
CHE
CHE
RPD
RPD
Q1 26
$1.5B
Q4 25
$1.5B
$1.7B
Q3 25
$1.6B
$1.7B
Q2 25
$1.7B
$1.6B
Q1 25
$1.7B
$1.6B
Q4 24
$1.7B
$1.7B
Q3 24
$1.8B
$1.6B
Q2 24
$1.7B
$1.5B
负债/权益比
CHE
CHE
RPD
RPD
Q1 26
0.11×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

现金流与资本效率

扣除再投资后实际产生的现金。现金流比净利润更难造假

指标
CHE
CHE
RPD
RPD
经营现金流最新季度
$88.2M
$37.6M
自由现金流经营现金流 - 资本支出
$36.4M
自由现金流率自由现金流/营收
16.8%
资本支出强度资本支出/营收
4.1%
0.5%
现金转化率经营现金流/净利润
1.33×
12.01×
过去12个月自由现金流最近4个季度
$146.2M

8季度趋势,按日历期对齐

经营现金流
CHE
CHE
RPD
RPD
Q1 26
$88.2M
Q4 25
$133.5M
$37.6M
Q3 25
$83.4M
$39.0M
Q2 25
$138.6M
$47.5M
Q1 25
$32.7M
$29.8M
Q4 24
$164.9M
$63.8M
Q3 24
$90.5M
$44.0M
Q2 24
$77.5M
$32.9M
自由现金流
CHE
CHE
RPD
RPD
Q1 26
Q4 25
$117.2M
$36.4M
Q3 25
$66.0M
$34.8M
Q2 25
$122.8M
$46.6M
Q1 25
$19.5M
$28.4M
Q4 24
$152.2M
$62.6M
Q3 24
$77.0M
$42.6M
Q2 24
$66.5M
$32.6M
自由现金流率
CHE
CHE
RPD
RPD
Q1 26
Q4 25
18.3%
16.8%
Q3 25
10.6%
16.0%
Q2 25
19.8%
21.8%
Q1 25
3.0%
13.5%
Q4 24
37.0%
28.9%
Q3 24
19.7%
19.9%
Q2 24
17.7%
15.7%
资本支出强度
CHE
CHE
RPD
RPD
Q1 26
4.1%
Q4 25
2.6%
0.5%
Q3 25
2.8%
1.9%
Q2 25
2.6%
0.4%
Q1 25
2.1%
0.6%
Q4 24
3.1%
0.5%
Q3 24
3.5%
0.6%
Q2 24
3.0%
0.1%
现金转化率
CHE
CHE
RPD
RPD
Q1 26
1.33×
Q4 25
1.74×
12.01×
Q3 25
1.30×
3.97×
Q2 25
2.64×
5.70×
Q1 25
0.46×
14.14×
Q4 24
1.83×
29.36×
Q3 24
1.19×
2.85×
Q2 24
1.09×
5.03×

财务流量对比

营收 → 毛利润 → 营业利润 → 净利润流向图

业务分部营收拆解

CHE
CHE

Homecare$371.1M88%
Inpatient$35.9M9%
Other$13.0M3%

RPD
RPD

Products$209.1M96%
Services$8.2M4%

相关对比